Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy.
about
Neuroprotection for ischemic stroke: past, present and futureClinical diagnosis of lacunar stroke in the first 6 hours after symptom onset: analysis of data from the glycine antagonist in neuroprotection (GAIN) Americas trial.Increased concentrations of both NMDA receptor co-agonists D-serine and glycine in global ischemia: a potential novel treatment target for perinatal asphyxia.The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trialThe ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011.Final infarct volume estimation on 1-week follow-up MR imaging is feasible and is dependent on recanalization status.Clinical pharmacological issues in the development of acute stroke therapies.Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders.Stromal-derived factor-1[alpha] correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patientsIntra- and interrater reliability of ischemic lesion volume measurements on diffusion-weighted, mean transit time and fluid-attenuated inversion recovery MRI.Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE)Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant.The role of glutamate in neuronal ischemic injury: the role of spark in fire.Quantitative Predictive Models for the Degree of Disability After Acute Ischemic Stroke.A multicenter, randomized trial on neuroprotection with remote ischemic per-conditioning during acute ischemic stroke: the REmote iSchemic Conditioning in acUtE BRAin INfarction study protocol.Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke.
P2860
Q24645185-1EBED24A-A21F-4C51-A709-1D8CD2E5123FQ30438504-4DCE36FB-E27F-418F-9DFA-63F1D30F4CE3Q30466599-96C6F2BA-D446-4B87-A397-9987F0FED699Q33848061-37C439FC-C0FF-4624-80C2-022345FE4FEBQ34020415-069B4822-4439-49FA-A7BD-E01D3F4A7864Q34545798-FB522D02-4331-4441-B860-7A3C33DA92B2Q36496990-2485F4E1-0BBF-410E-87CB-013DDF2CF3D1Q36561991-A9DBB26B-D92E-47C2-93B2-0B6F65BA6F59Q36572996-BFAFB7FA-D5AA-412F-B29F-2A3D14D2ABD3Q36623736-8596FF38-7A0A-4F51-A4FA-C4F9BCC3464FQ37252669-ECB00789-7112-49E8-9711-E0018F620474Q37340226-382C64C4-F5CD-4ADB-833F-B6E53E4DB40EQ37951747-2277D81B-CD3D-4533-ABEE-6BD66A19B832Q47384535-3A3FDD8B-E5D7-48DE-A883-2E350BCFAB0FQ48625008-DC2F2101-8DE5-4106-BA7E-6ABA8888322CQ48728908-6845AE78-A82C-4A59-B6B4-158B03AAA142
P2860
Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Effect of the Glycine Antagoni ...... trial: The GAIN MRI Substudy.
@ast
Effect of the Glycine Antagoni ...... trial: The GAIN MRI Substudy.
@en
type
label
Effect of the Glycine Antagoni ...... trial: The GAIN MRI Substudy.
@ast
Effect of the Glycine Antagoni ...... trial: The GAIN MRI Substudy.
@en
prefLabel
Effect of the Glycine Antagoni ...... trial: The GAIN MRI Substudy.
@ast
Effect of the Glycine Antagoni ...... trial: The GAIN MRI Substudy.
@en
P2093
P2860
P356
P1476
Effect of the Glycine Antagoni ...... trial: The GAIN MRI Substudy.
@en
P2093
Ajaz Rashid
David Chiu
David Kaufman
GAIN MRI Substudy
Kennedy R Lees
Linda Clayton
Marc Fisher
Marie Luby
Steven Warach
Thomas Devlin
P2860
P304
P356
10.1159/000090208
P577
2005-12-09T00:00:00Z